Baxter Bros’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Baxter Bros's IBB Position: Q3 2026 in Review
Baxter Bros increased its iShares Biotechnology ETF (IBB) stake by 4.6% in Q3 2026, buying an estimated $45.5K and bringing the position to 5,176 shares worth $1.09M. The position accounts for 0.12% of the portfolio, ranked #93.
Baxter Bros first reported a position in IBB in Q3 2023 and has held it in 12 quarters since. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Baxter Bros held 5,176 shares of iShares Biotechnology ETF worth $1.09M as of Q3 2026.
- Baxter Bros bought 227 iShares Biotechnology ETF shares in Q3 2026, an estimated $45.5K.
- iShares Biotechnology ETF made up 0.12% of Baxter Bros's portfolio in Q3 2026, its #93 holding.
- Baxter Bros first reported a position in iShares Biotechnology ETF in Q3 2023 and has held it in 12 quarters since.
- 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Baxter Bros's 13F filing for Q3 2026, filed 4 Nov 2026.